Hypothyroidism: playing the cardiometabolic risk concerto
Abstract Background Thyroid hormones influence the function of essentially every system of the body, including the cardiovascular and metabolic system. Thyroid hormone replacement with levothyroxine (LT4) is the mainstay of pharmacological management for people with (especially clinically overt) hyp...
Saved in:
| Main Authors: | George J. Kahaly, Youshuo Liu, Luca Persani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Thyroid Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13044-025-00233-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of hypothyroidism with the combination of levothyroxine and slow-release triiodothyronine: a randomized clinical trial
by: F. Azizi, et al.
Published: (2025-06-01) -
Prevalence of cardiometabolic risk factors in patients with hypertension and subclinical hypothyroidism
by: A. O. Radchenko, et al.
Published: (2021-11-01) -
Prevalence of Subclinical Hypothyroidism in a Non-Diabetic Young Female Population and Its Impact on Diabetes and Cardiometabolic Risk
by: Nawoda Hewage, et al.
Published: (2024-12-01) -
Primary and residual cardiometabolic risk factors among young adults in a Russian city
by: Albina V. Sineglazova, et al.
Published: (2024-10-01) -
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism
by: Marco Centanni, et al.
Published: (2025-07-01)